UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Enhanced antitumor activity of a novel, oral, helper epitope-containing WT1 protein vaccine in a model of murine leukemia

BMC cancer, 2023-02, Vol.23 (1), p.167-167, Article 167

2023

Volltextzugriff (PDF)

Skeletal dysplasia in adenosine deaminase deficiency

Pediatrics international, 2022-01, Vol.64 (1), p.e15214-n/a

2022

Volltextzugriff (PDF)

Distinct difference in tumor-infiltrating immune cells between Wilms’ tumor gene 1 peptide vaccine and anti-programmed cell death-1 antibody therapies

Neuro-oncology advances, 2021-01, Vol.3 (1), p.vdab091-vdab091

2021

Volltextzugriff (PDF)

An oral WT1 protein vaccine composed of WT1-anchored, genetically engineered Bifidobacterium longum allows for intestinal immunity in mice with acute myeloid leukemia

Cancer Immunology, Immunotherapy, 2023-01, Vol.72 (1), p.39-53

2023

Volltextzugriff (PDF)

The anti-tumor effect of oral cancer vaccine using Bifidobacterium as a platform for displaying Wilms’ tumor 1 protein

Journal of clinical oncology, 2019-03, Vol.37 (8_suppl), p.72-72

2019

Volltextzugriff (PDF)

A Case of Thoracoscopic Esophagectomy for Thoracic Esophageal Cancer with Tracheal Diverticulum

Nihon Rinshō Geka Gakkai zasshi, 2023, Vol.84 (11), p.1737-1742

2023

Volltextzugriff (PDF)

Effects of ipragliflozin on the development and progression of kidney disease in patients with type 2 diabetes: An analysis from a multicenter prospective intervention study

Journal of diabetes investigation, 2020-09, Vol.11 (5), p.1248-1257

2020

Volltextzugriff (PDF)

The safety, efficacy and predictors for HbA1c reduction of sitagliptin in the treatment of Japanese type 2 diabetes

Diabetes research and clinical practice, 2012-01, Vol.95 (1), p.e20-e22

2012

Volltextzugriff (PDF)

A Prospective Intervention Study on the Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes in Kanagawa

Journal of the Japan Diabetes Society, 2019/10/30, Vol.62(10), pp.649-658

2019

Volltextzugriff (PDF)

Two-year assessment of the efficacy and safety of sitagliptin in elderly patients with type 2 diabetes: Post hoc analysis of the ASSET-K study

BMC endocrine disorders, 2015-07, Vol.15 (1), p.34-34, Article 34

2015

Volltextzugriff (PDF)

Efficacy and safety of sitagliptin monotherapy and combination therapy in Japanese type 2 diabetes patients

Journal of diabetes investigation, 2012-12, Vol.3 (6), p.503-509

2012

Volltextzugriff (PDF)

Effects of sitagliptin on the serum creatinine in Japanese type 2 diabetes

Diabetes research and clinical practice, 2015-06, Vol.108 (3), p.e42-e45

2015

Volltextzugriff (PDF)

Effects of acupuncture stimulation on blood glucose concentration in the Otsuka Long-Evans Tokushima Fatty (OLETF) rat, an animal model for type-2 diabetes mellitus

Medical science monitor. Basic research, 2014-05, Vol.20, p.70-75

2014

Volltextzugriff (PDF)

Safety and efficacy of adding sitagliptin to insulin in patients with type 2 diabetes: The ASSIST-K study

Diabetes research and clinical practice, 2014-03, Vol.103 (3), p.e30-e33

2014

Volltextzugriff (PDF)

The Efficacy of 5-Year Treatment With Sitagliptin in Japanese Patients With Type 2 Diabetes and the Factors for Maintaining Better Glycemic Control

Journal of the Japan Diabetes Society, 2018/11/30, Vol.61(11), pp.773-779

2018

Volltextzugriff (PDF)

Efficacy and Safety of Ipragliflozin in Patients With Type 2 Diabetes: ASSIGN-K Study

Journal of endocrinology and metabolism, 2019-06, Vol.9 (3), p.51-62

2019

Volltextzugriff (PDF)

Clinical effects of liraglutide on diabetes control in Japanese type 2 diabetes mellitus patients

Diabetology international, 2014-06, Vol.5 (2), p.98-104

2014

Volltextzugriff (PDF)

日本人2型糖尿病患者に対するイプラグリフロジン投与52週間の有効性と安全性に関する前向き介入研究

糖尿病, 2019/10/30, Vol.62(10), pp.649-658

2019

Volltextzugriff (PDF)

Ipragliflozin Improves Glycemic Control and Decreases Body Fat in Patients With Type 2 Diabetes Mellitus

Journal of clinical medicine research, 2017-07, Vol.9 (7), p.586-595

2017

Volltextzugriff (PDF)

Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study

Journal of clinical medicine research, 2016-02, Vol.8 (2), p.116-125

2016

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(12)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(28)

Sprache

Englisch
(24)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(13)
Science & Technology
(13)
Original
(10)
Endocrinology & Metabolism
(9)
Female
(6)
Humans
(6)
Male
(6)
Sitagliptin
(6)
Middle Aged
(5)
Aged
(4)
Body Weight
(4)
Diabetes Mellitus, Type 2 - Drug Therapy
(4)
Type 2 Diabetes
(4)
Animals
(3)
Care And Treatment
(3)
Diabetes
(3)
Diabetes Mellitus, Type 2 - Blood
(3)
Dipeptidyl Peptidase-4 Inhibitor
(3)
Dipeptidyl-Peptidase Iv Inhibitors - Therapeutic Use
(3)
Glycated Hemoglobin A - Metabolism
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Enhanced antitumor activity of a novel, oral, helper epitope-containing WT1 protein vaccine in a model of murine leukemia

Skeletal dysplasia in adenosine deaminase deficiency

Distinct difference in tumor-infiltrating immune cells between Wilms’ tumor gene 1 peptide vaccine and anti-programmed cell death-1 antibody therapies

An oral WT1 protein vaccine composed of WT1-anchored, genetically engineered Bifidobacterium longum allows for intestinal immunity in mice with acute myeloid leukemia

The anti-tumor effect of oral cancer vaccine using Bifidobacterium as a platform for displaying Wilms’ tumor 1 protein

A Case of Thoracoscopic Esophagectomy for Thoracic Esophageal Cancer with Tracheal Diverticulum

Effects of ipragliflozin on the development and progression of kidney disease in patients with type 2 diabetes: An analysis from a multicenter prospective intervention study

The safety, efficacy and predictors for HbA1c reduction of sitagliptin in the treatment of Japanese type 2 diabetes

A Prospective Intervention Study on the Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes in Kanagawa

Two-year assessment of the efficacy and safety of sitagliptin in elderly patients with type 2 diabetes: Post hoc analysis of the ASSET-K study

Efficacy and safety of sitagliptin monotherapy and combination therapy in Japanese type 2 diabetes patients

Effects of sitagliptin on the serum creatinine in Japanese type 2 diabetes

Effects of acupuncture stimulation on blood glucose concentration in the Otsuka Long-Evans Tokushima Fatty (OLETF) rat, an animal model for type-2 diabetes mellitus

Safety and efficacy of adding sitagliptin to insulin in patients with type 2 diabetes: The ASSIST-K study

The Efficacy of 5-Year Treatment With Sitagliptin in Japanese Patients With Type 2 Diabetes and the Factors for Maintaining Better Glycemic Control

Efficacy and Safety of Adding Sitagliptin in Type 2 Diabetes Patients on Insulin: Age-Stratified Comparison at One Year in the ASSIST-K Study

Efficacy and Safety of Ipragliflozin in Patients With Type 2 Diabetes: ASSIGN-K Study

Add-On Sitagliptin Therapy for Insulin-Treated Type 2 Diabetes: An Analysis of Hemoglobin A1c and Other Variables Using ASSIST-K Follow-Up Data

Clinical effects of liraglutide on diabetes control in Japanese type 2 diabetes mellitus patients

日本人2型糖尿病患者に対するイプラグリフロジン投与52週間の有効性と安全性に関する前向き介入研究

Effectiveness of Ipragliflozin for Reducing Hemoglobin A1c in Patients With a Shorter Type 2 Diabetes Duration: Interim Report of the ASSIGN-K Study

Ipragliflozin Improves Glycemic Control and Decreases Body Fat in Patients With Type 2 Diabetes Mellitus

Correction: Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study

Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study

Factors Predicting Therapeutic Efficacy of Combination Treatment With Sitagliptin and Insulin in Type 2 Diabetic Patients: The ASSIST-K Study

Suchergebnisse filtern